{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T10:44:49Z","timestamp":1791801889604,"version":"4.3.4"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CNSAMC"],"published-print":{"date-parts":[[2026,10,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Traumatic spinal cord injury (TSCI) is a catastrophic insult to the central nervous\nsystem (CNS) and often leaves patients with profound, long-term neurological disability. In this\nstudy, we evaluated whether dexpanthenol, a vitamin B5 precursor, exerts neuroprotective effects in a rat\nmodel of TSCI. We also sought to clarify the mechanisms that might account for any observed benefit,\nfocusing on pathways related to apoptosis, inflammation, oxidative stress, and ferroptosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We used Wistar albino rats and allocated them into four groups: Control, Sham, Trauma, and\nDexpanthenol. Animals in the sham group underwent laminectomy alone. In contrast, rats in the trauma\nand dexpanthenol groups received a standardized contusion injury created by dropping a 10 g weight\nfrom 10 cm onto the exposed spinal cord. Immediately after injury, we administered dexpanthenol intraperitoneally\n(i.p.) to the treatment group. Neurological function was evaluated 24 h later using the Basso,\nBeattie, and Bresnahan (BBB) locomotor rating scale. Biochemical analyses were performed on tissue\nsamples to measure markers of apoptosis (Caspase-3), inflammation (Myeloperoxidase, MPO), lipid peroxidation\n(Malondialdehyde, MDA), oxidative stress (Xanthine Oxidase, XO, Catalase, CAT), and ferroptosis\n(Glutathione, GSH, Glutathione Peroxidase 4, GPX4, Acyl-CoA Synthetase Long Chain Family\nMember 4, ACSL4, and Solute Carrier Family 7 Member 11, SLC7A11). Moreover, we prepared hematoxylin\nand eosin (H&amp;E) stained sections and carried out a semi-quantitative histopathological evaluation\nbased on these slides.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Relative to the sham condition, spinal cord contusion produced a clear functional deterioration,\nwith BBB locomotor scores dropping sharply and histopathological injury becoming more pronounced.\nIn parallel, the trauma group showed substantial biochemical increases in caspase-3, MPO, MDA, XO,\nand ACSL4. In contrast, antioxidant and ferroptosis-related defenses were suppressed after injury, as reflected\nby significantly lower CAT, GSH, GPX4, and SLC7A11 levels. Administration of dexpanthenol\nshifted this profile. Animals receiving treatment performed better on the BBB scale than untreated trauma\nrats, indicating a significant recovery of neurological function. Consistently, tissue damage on histology\nwas attenuated, pro-apoptotic and pro-oxidant markers (caspase-3, MPO, MDA, XO, and ACSL4)\nwere reduced, and the depleted protective factors (CAT, GSH, GPX4, and SLC7A11) were brought back\ntoward baseline in a statistically significant manner.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>The restoration of antioxidant defenses and the specific inhibition of lipid peroxidation\nmarkers suggest that dexpanthenol's efficacy extends beyond general anti-inflammatory effects. By targeting\nferroptosis-associated molecular changes via the preservation of the GPX4\/GSH axis, dexpanthenol\naddresses a fundamental mechanism of secondary neuronal death. These findings highlight the\ntherapeutic relevance of stabilizing membrane lipids and cellular energetics in the acute phase of neurotrauma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Taken together, our data suggest that dexpanthenol provides significant protection in the\nsetting of TSCI. The benefit seems to arise from a multi-pronged profile: it inhibits apoptosis and inflammation,\nlimits oxidative damage, and attenuates key components of the ferroptotic cascade. In light\nof these converging effects, dexpanthenol warrants further investigation as a candidate therapy for TSCI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0118715249476221260930032152","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T09:47:20Z","timestamp":1791798440000},"source":"Crossref","is-referenced-by-count":0,"title":["Neuroprotective Profile of Dexpanthenol in Traumatic Spinal Cord Injury:\nA Focus on the Inhibition of Ferroptotic Cell Death"],"prefix":"10.2174","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0234-5697","authenticated-orcid":true,"given":"\u0130l\u00e7im","family":"Ermutlu","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, \u015e\u0131rnak State Hospital, \u015e\u0131rnak, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1270-2408","authenticated-orcid":true,"given":"\u015eerife Efsun","family":"Antmen","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, Mersin University,Faculty of Pharmacy, Mersin, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6786-4477","authenticated-orcid":true,"given":"Tolga","family":"Akbiyik","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ministry of Health Adana City Education andResearch Hospital, Adana, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1047-8783","authenticated-orcid":true,"given":"Hamide","family":"Sayar","sequence":"additional","affiliation":[{"name":"Department of Pathology, Mersin University, Faculty of Medicine, Mersin, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Central Nervous System Agents in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715249476221260930032152","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/259166\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715249476221260930032152","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T09:47:24Z","timestamp":1791798444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/259166\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118715249476221260930032152","relation":{},"ISSN":["1871-5249"],"issn-type":[{"value":"1871-5249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,2]]}}}